These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Split vector systems for ultra-targeted gene delivery: a contrivance to achieve ethical assurance of somatic gene therapy in vivo. Tolmachov OE Med Hypotheses; 2014 Aug; 83(2):211-6. PubMed ID: 24854575 [TBL] [Abstract][Full Text] [Related]
3. Tightly-wound miniknot vectors for gene therapy: a potential improvement over supercoiled minicircle DNA. Tolmachov OE Med Hypotheses; 2010 Apr; 74(4):702-4. PubMed ID: 19914006 [TBL] [Abstract][Full Text] [Related]
4. Subcellular post-transcriptional targeting: delivery of an intracellular protein to the extracellular leaflet of the plasma membrane using a glycosyl-phosphatidylinositol (GPI) membrane anchor in neurons and polarised epithelial cells. Brown O; Cowen RL; Preston CM; Castro MG; Lowenstein PR Gene Ther; 2000 Nov; 7(22):1947-53. PubMed ID: 11127583 [TBL] [Abstract][Full Text] [Related]
5. Stent-mediated gene delivery for site-specific transgene administration to the airway epithelium and management of tracheobronchial tumors. Kruklitis RJ; Fishbein I; Singhal S; Kapoor V; Levy RJ; Alferiev IS; Sterman DH Respiration; 2014; 88(5):406-17. PubMed ID: 25323160 [TBL] [Abstract][Full Text] [Related]
6. Trans-complementation of vector replication versus Coxsackie-adenovirus-receptor overexpression to improve transgene expression in poorly permissive cancer cells. Fechner H; Wang X; Wang H; Jansen A; Pauschinger M; Scherübl H; Bergelson JM; Schultheiss HP; Poller W Gene Ther; 2000 Nov; 7(22):1954-68. PubMed ID: 11127584 [TBL] [Abstract][Full Text] [Related]
7. Transgenic DNA modules with pre-programmed self-destruction: Universal molecular devices to escape 'genetic litter' in gene and cell therapy. Tolmachov OE Med Hypotheses; 2015 Nov; 85(5):686-9. PubMed ID: 26319641 [TBL] [Abstract][Full Text] [Related]
8. Virus-mimetic polyplex particles for systemic and inflammation-specific targeted delivery of large genetic contents. Kang S; Lu K; Leelawattanachai J; Hu X; Park S; Park T; Min IM; Jin MM Gene Ther; 2013 Nov; 20(11):1042-52. PubMed ID: 23759703 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing. Ulrich-Vinther M Acta Orthop Suppl; 2007 Apr; 78(325):1-64. PubMed ID: 17427340 [TBL] [Abstract][Full Text] [Related]
10. Self-entanglement of long linear DNA vectors using transient non-B-DNA attachment points: a new concept for improvement of non-viral therapeutic gene delivery. Tolmachov OE Med Hypotheses; 2012 May; 78(5):632-5. PubMed ID: 22356834 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter. Määttä AM; Korja S; Venhoranta H; Hakkarainen T; Pirinen E; Heikkinen S; Pellinen R; Mäkinen K; Wahlfors J Int J Mol Med; 2006 Nov; 18(5):901-8. PubMed ID: 17016620 [TBL] [Abstract][Full Text] [Related]
12. Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Miller N; Whelan J Hum Gene Ther; 1997 May; 8(7):803-15. PubMed ID: 9143906 [TBL] [Abstract][Full Text] [Related]
15. Catheter-based adenovirus-mediated local intravascular gene delivery of a soluble TGF-beta type II receptor using an infiltrator in porcine coronary arteries: efficacy and complications. Chung IM; Ueno H; Pak YK; Kim JW; Choi DH; Shin GJ; Yang WI; Jang Ys Exp Mol Med; 2002 Sep; 34(4):299-307. PubMed ID: 12515396 [TBL] [Abstract][Full Text] [Related]
16. Hybrid vector designs to control the delivery, fate and expression of transgenes. Lam PY; Breakefield XO J Gene Med; 2000; 2(6):395-408. PubMed ID: 11199260 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS. Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012 [TBL] [Abstract][Full Text] [Related]
18. Uptake of adenoviral vectors via fibroblast growth factor receptors involves intracellular pathways that differ from the targeting ligand. Hoganson DK; Sosnowski BA; Pierce GF; Doukas J Mol Ther; 2001 Jan; 3(1):105-12. PubMed ID: 11162317 [TBL] [Abstract][Full Text] [Related]
19. Tight regulation from a single tet-off rAAV vector as demonstrated by flow cytometry and quantitative, real-time PCR. Jiang L; Rampalli S; George D; Press C; Bremer EG; O'Gorman MR; Bohn MC Gene Ther; 2004 Jul; 11(13):1057-67. PubMed ID: 15152187 [TBL] [Abstract][Full Text] [Related]
20. A novel strategy of cell targeting based on tissue-specific expression of the ecotropic retrovirus receptor gene. Igarashi T; Suzuki S; Takahashi M; Tamaoki T; Shimada T Hum Gene Ther; 1998 Dec; 9(18):2691-8. PubMed ID: 9874267 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]